Impact of RADA16 Use on Outcomes Following Tonsillectomy in Children

Recruiting now · Phase 2

Conditions studied: Postoperative Pain

In brief

The purpose of the research is to determine if RADA16 (also known as PuraStat®, PuraGel®, or PuraSinus®) improves patient outcomes following pediatric tonsillectomy procedures. Researchers will compare application of device RADA16 to application of no device to see if RADA16 works to treat post tonsillectomy hemorrhage.Participants will: Undergo tonsillectomy procedure. Receive and fill out a survey sent via email every 2 days following their procedure for 15 days, plus an additional survey on day 30, and track their symptoms.

Key facts

Study ID
NCT07188779
Run by
Rutgers, The State University of New Jersey
People needed
134
Starts
2026-07-09
Expected to finish
2027-12-01
Last updated by the study team
2026-07-22

Who can join

Age: 3 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.